Tesla
TSLA
Adobe
ADBE
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
US Stock MarketDetailed Quotes
BLUE bluebird bio
- 3.850
- -0.070-1.79%
Close Mar 25 16:00 ET
37.50MMarket Cap-0.11P/E (TTM)
3.910High3.810Low244.28KVolume3.890Open3.920Pre Close941.11KTurnover2.53%Turnover RatioLossP/E (Static)9.74MShares28.60052wk High-6.48P/B37.25MFloat Cap3.56052wk Low--Dividend TTM9.68MShs Float3057.654Historical High--Div YieldTTM2.55%Amplitude3.560Historical Low3.852Avg Price1Lot Size
About bluebird bio Company
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Company Profile
SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees375
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300
Websitehttp://www.bluebirdbio.com
Company Executives
- Name
- Position
- Salary
- Andrew Obenshain
- Director, President and Chief Executive Officer
- 3.05M
- O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
- O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
- Richard A. Colvin
- Chief Medical Officer
- 1.34M
- Joseph Vittiglio
- Chief Legal and Business Officer
- --
- Thomas J. Klima
- Chief Commercial and Operating Officer
- 1.33M
- Mark Vachon
- Chairman of the Board
- 200.91K
- Michael Cloonan
- Director
- --
- Nick Leschly
- Director
- 96.41K
- Dr. Charlotte Jones-Burton, M.D.,M.S.
- Independent Director
- 146.41K
- Dr. John O. Agwunobi, M.D.
- Independent Director
- 160.91K
- Najoh Tita-Reid
- Independent Director
- 153.91K
- Richard Paulson, M.B.A.
- Independent Director
- 65.24K
- Dr. Elisabeth Leiderman, M.D.
- Independent Director
- 167.91K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
